Ikonisys SA announced that they have entered into a collaboration agreement to support the international market introduction and further expansion of Ikonisys' novel and platform technology, the Ikoniscope20 system, in the European and US markets. As a reminder, the ikoniscope20 is the digital fluorescence microscope system of Ikonisys. It is a fully integrated technology platform comprising hardware, software and consumables, providing fully automated slide handling, cell detection and analysis, data capture, data storage and review.

Ikoniscope20 runs several FISH applications (technique that identifies and localizes specific genes in cell suspensions or tissues) routinely used by US and EU oncology labs, but can also identify and analyze very promising rare and hard to be detected cells like CTC for early cancer detection or treatment monitoring. This partnership with Evosciences will support the ramp-up of Ikonisys' two-fold worldwide commercialization strategy, on one side expanding the United States customer base, starting from converting current customers to active Ikoniscope20 users, and, on the other, focusing on direct commercialization in Europe. Ikonisys targets respectively a total available market of 7,326 laboratories and 3,824 laboratories.